A comprehensive view of Injectables / Infusions / IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease
Published: April 19, 2024 by Business Wire
Health Canada approves Merck & Co's KEYTRUDA in combination with chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma treatment following successful Phase 3 trial
Published: April 19, 2024 by EquityBites
High demand for injectable weight-loss drugs has led to supply issues, with most varieties listed in short supply by the FDA; Eli Lilly reports shortages of its Zepbound and Mounjaro could last until 2025
Published: April 19, 2024 by CBS - 12 WJTV (Jackson, MS)
Boston Scientific recalls Obsidio Conformable Embolic blood flow blocking agent due to safety issues; the product is used to block blood supply to tumors and to treat bleeding in patients
Published: April 18, 2024 by MedTech Dive
Medincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies; deal includes development of up to six injectables across multiple therapeutic areas
Published: April 17, 2024 by Business Wire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count